FRIDAY, Sept. 20, 2024 -- Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk...

FRIDAY, Sept. 27, 2024 -- An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer...

MONDAY, Sept. 16, 2024 -- For patients undergoing treatment for certain types of cancer, artificial intelligence (AI) can use electrocardiographic...

TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...

THURSDAY, Sept. 19, 2024 -- For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer...

THURSDAY, Sept. 26, 2024 -- For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does...

FRIDAY, Sept. 20, 2024 -- For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy,...

FRIDAY, Sept. 20, 2024 -- High levels of well-being may protect against the risks for cardiovascular diseases (CVDs), according to a study published...

TUESDAY, Sept. 24, 2024 -- Nearly half of patients with cancer experience some level of financial hardship (FH), according to a study published...

WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...